IL17A and neoplasm: To better understand the role of these CD4+ T cell subsets in tumor protection induced by EVax immunization, we examined the impact of neutralizing IFN‐γ (the major cytokine player of Th1 cells) and IL‐17a (the major cytokine player of Th17 cells) in EVax‐treated mice (Figure 3H).